4,5-MDO-DMT

Other names4,5-Methylenedioxy-N,N-dimethyltryptamine

ATC code

• None

Onset of actionUnknown^[1]

Duration of actionUnknown^[1]

4,5-MDO-DMT

Clinical data
Other names	4,5-Methylenedioxy-N,N-dimethyltryptamine
ATC code	None
Pharmacokinetic data
Onset of action	Unknown[1]
Duration of action	Unknown[1]
Identifiers
IUPAC name 2-(2H,6H-[1,3]dioxolo[4,5-e]indol-8-yl)-N,N-dimethylethan-1-amine
CAS Number	81249-30-1 N
PubChem CID	44278540
ChemSpider	23126498 N
UNII	L83E2J7P8Z
ChEMBL	ChEMBL28354 N
CompTox Dashboard (EPA)	DTXSID201027182
Chemical and physical data
Formula	C13H16N2O2
Molar mass	232.283 g·mol−1
3D model (JSmol)	Interactive image
Melting point	93 to 95 °C (199 to 203 °F) [2]
SMILES CN(C)CCC1=CNC2=C1C(OCO3)=C3C=C2
InChI InChI=1S/C13H16N2O2/c1-15(2)6-5-9-7-14-10-3-4-11-13(12(9)10)17-8-16-11/h3-4,7,14H,5-6,8H2,1-2H3 Key:ZMKRWFZFMOKVCP-UHFFFAOYSA-N
NY (what is this?)  (verify)

4,5-MDO-DMT, or 4,5-methylenedioxy-N,N-dimethyltryptamine, is a lesser-known psychedelic drug of the tryptamine family.^[1] It is the 4,5-methylenedioxy derivative of dimethyltryptamine (DMT) and is an analogue of psilocin (4-HO-DMT) and 5-MeO-DMT.^[1] The drug was included as an entry in Alexander Shulgin's 1997 book TiHKAL (Tryptamines I Have Known and Loved), but it was not tested to determine its psychoactive effects and its dose and duration are unknown.^[1] Studies in rodents found that its potential hallucinogenic potency is less than that of 4,5-MDO-DiPT but greater than that of 5,6-MDO-DiPT.^[2] Its chemical synthesis has been described.^[1] 4,5-MDO-DMT was first described in the scientific literature by Toni B. Kline and colleagues in 1982.^[2]